Skip to main content

Category Archives: CoolSculpting

December 4, 2024

Top Reasons to Choose Sculptra for a NonSurgical ButtLift

When it comes to enhancing curves and achieving a fuller, more lifted look, many people think of traditional Brazilian Butt Lift (BBL) surgery or implants. However, not everyone wants to undergo an invasive procedure with extensive downtime and potential risks. This is where Sculptra comes in—a revolutionary non-surgical alternative for butt augmentation. Sculptra, originally designed […]

Read More
emsculpt and coolsculpt
December 13, 2021

EmSculpt vs. CoolSculpting

Is a slim, toned, or chiseled body in your future? At the Dermatology Institute of Southern California, it could be. If dieting and exercising alone are not giving you the body you desire, EmSculpt or CoolSculpting can help. Both procedures are FDA-approved and highly advantageous to patients like yourself who struggle with stubborn, troublesome fat […]

Read More
April 15, 2019

CoolSculpting for Non-Surgical Fat Reduction

There are many body fat reduction methods available nowadays – everything from liposuction to Jenny Craig. While the options to reduce excess body fat are plentiful, cryolipolysis – otherwise known as CoolSculpting – is an FDA-approved laser treatment that does NOT require surgery. A CoolSculpting treatment is fast. A patient can come in on their […]

Read More
July 14, 2014

Voluma™ XC in Los Angeles

The aging process affects many aspects of our face, but one of the most noticeable changes is the loss of volume. Several injectable fillers, including others from Juvederm®, have been developed to replace lost volume in the skin and reduce the appearance of wrinkles, but no filler has before now been FDA-approved for use in […]

Read More

A link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided for informational purposes only. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.